|
AP2536B-ev
|
Abcepta, Inc.
|
ACSL4 [FACL4] [Centre] [RB04697], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP2536B
|
Abcepta, Inc.
|
ACSL4 [FACL4] [Centre] [RB04697], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP11173a-ev
|
Abcepta, Inc.
|
MIER2 [N-term] [RB28951], Rabbit Polyclonal Antibody
|
Human
|
WB, FC
|
|
|
AP11173a
|
Abcepta, Inc.
|
MIER2 [N-term] [RB28951], Rabbit Polyclonal Antibody
|
Human
|
WB, FC
|
|
|
AP21169a-ev
|
Abcepta, Inc.
|
UBE2N [Centre] [RB49505], Rabbit Polyclonal Antibody
|
Human, Rat
|
WB
|
|
|
AP21169a
|
Abcepta, Inc.
|
UBE2N [Centre] [RB49505], Rabbit Polyclonal Antibody
|
Human, Rat
|
WB
|
|
|
AM2220b-ev
|
Abcepta, Inc.
|
USP14 [N-term] [889CT6.2.1], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB
|
|
|
AM2220b
|
Abcepta, Inc.
|
USP14 [N-term] [889CT6.2.1], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB
|
|
|
PDC03-0100
|
Bio-Helix Co., Ltd
|
PureDireX Virus Nucleic Acid Isolation Kit
|
|
|
|
|
ATGA0195-100ul
|
NKMax Bio (ATGen)
|
Caveolin-1 [AT4C1], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB, ICC/IF
|
|
|
ATGA0195-50ul
|
NKMax Bio (ATGen)
|
Caveolin-1 [AT4C1], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB, ICC/IF
|
|
|
ATGA0387-100ul
|
NKMax Bio (ATGen)
|
LMW-PTP/ACP1 [AT5C11], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB, ICC/IF
|
|
|
ATGA0387-50ul
|
NKMax Bio (ATGen)
|
LMW-PTP/ACP1 [AT5C11], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB, ICC/IF
|
|
|
ATGP3312-250ug
|
NKMax Bio (ATGen)
|
Carboxypeptidase A4/CPA4 [17-421 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP3312-50ug
|
NKMax Bio (ATGen)
|
Carboxypeptidase A4/CPA4 [17-421 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
GTX42218
|
GeneTex International Corporation
|
CD244 [2B4.69] (Low endotoxin, azide free), Mouse Monoclonal Antibody
|
Human
|
FACS, IP
|
|
|
HY-116214-50mg
|
MedChemexpress LLC
|
Cyprodinil [CAS 121552-61-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-116214S-5mg
|
MedChemexpress LLC
|
Cyprodinil-d5 [CAS 1773496-67-5]
|
|
|
|
|
HY-13438-10mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-25mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-5mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-13438-50mg
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9]
|
|
Cancer-programmed cell death
|
|
|
HY-14270-10mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-100mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-14270-200mg
|
MedChemexpress LLC
|
Lodoxamide [CAS 53882-12-5]
|
|
COVID-19-immunoregulation
|
|
